SCHEMBL7541876

SCHEMBL7541876

Oc1cccc2c(Sc3cccc4ccccc34)cccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
IFNAR1 P17181 1/20 0.49
ALDH1A1 P00352 3/20 0.47
LMNA P02545 3/20 0.47
MAPK1 P28482 2/20 0.47
NPY1R P25929 1/20 0.47
NPY2R P49146 1/20 0.47
IDO1 P14902 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
USP2 O75604 1/20 0.42
PAK1 Q13153 1/20 0.42
RECQL P46063 2/20 0.42
MAPT P10636 2/20 0.42
PTPN22 Q9Y2R2 1/20 0.42
TRPM4 Q8TD43 1/20 0.42
RAD52 P43351 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7191375 0.94 CYP1A2 (0.54) CYP1A2IFNAR1ALDH1A1LMNAMAPK1
SCHEMBL31167972 0.85 IFNAR1 (0.60) CYP1A2IFNAR1ALDH1A1LMNAMAPK1
SCHEMBL577858 0.85 IFNAR1 (0.60) CYP1A2IFNAR1ALDH1A1LMNAMAPK1
SCHEMBL30548749 0.83 IFNAR1 (0.58) CYP1A2IFNAR1ALDH1A1LMNAMAPK1
SCHEMBL11261233 0.81 IDO1 (0.65) CYP1A2IDO1USP2PAK1RECQL
SCHEMBL22647149 0.80 CYP1A2 (0.47) CYP1A2IFNAR1ALDH1A1LMNAMAPK1
1-Naphthol SCHEMBL8119253 0.80 CYP1A2 (0.94) CYP1A2ALDH1A1LMNAIDO1SMN1; SMN2
1-Naphthol SCHEMBL273260 0.78 CYP1A2 (1.00) CYP1A2ALDH1A1LMNAIDO1SMN1; SMN2
1-Naphthol SCHEMBL10486461 0.78 CYP1A2 (1.00) CYP1A2ALDH1A1LMNAIDO1SMN1; SMN2
1-Naphthol SCHEMBL29767730 0.78 CYP1A2 (1.00) CYP1A2ALDH1A1LMNAIDO1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 CYP1A2 1275/4885IFNAR1 4755/4885ALDH1A1 1488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.